The NOS/sGC pathway in the rat central nervous system: A microdialysis overview

Neurochemistry International

Volumn 45, Issue 6, 2004, Pages 787-797

  Pepicelli, Olimpia ^a   Raiteri, Maurizio ^a   Fedele, Ernesto ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

amino 3 hydroxy 5 methylisoxazole 4 propionic acid; 7 chloro kynurenic acid; 7 Cl KYNA; 7 NINA; 7 nitroindazole monosodium salt; AMPA; carbon monoxide; cGMP; CO; cyclic GMP, guanosine 3 :5 cyclic monophosphate; DNQX

Indexed keywords

6,7 DINITRO 2,3 QUINOXALINEDIONE; 7 CHLOROKYNURENIC ACID; 7 NITROINDAZOLE; ALUMINUM; AMPA RECEPTOR ANTAGONIST; CALMODULIN; CYCLOTHIAZIDE; DIZOCILPINE; GALANIN; GUANYLATE CYCLASE; HEME OXYGENASE INHIBITOR; ISOBUTYLMETHYLXANTHINE; KYNURENIC ACID DERIVATIVE; MECAMYLAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROSO N ACETYLPENICILLAMINE; PENICILLAMINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PROLYLALANYLLEUCYLALANINAMIDE; PROTEIN INHIBITOR; PROTOPORPHYRIN ZINC; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANOREXIA; BASAL CELL; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CIRCADIAN RHYTHM; COGNITION; CONFERENCE PAPER; DIZZINESS; ENZYME ACTIVITY; FOREBRAIN; FRONTAL CORTEX; GRANULE CELL; HEADACHE; HIPPOCAMPUS; HYPERPOLARIZATION; LEARNING; LUTEINIZING HORMONE BLOOD LEVEL; LUTEINIZING HORMONE RELEASE; MEMORY; MICRODIALYSIS; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NEUROTOXICITY; NONHUMAN; OLFACTORY BULB; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN LOCALIZATION; PURKINJE CELL; PYRAMIDAL NERVE CELL; STATISTICAL SIGNIFICANCE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBRAL CORTEX; GUANYLATE CYCLASE; HIPPOCAMPUS; HUMANS; MICRODIALYSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 4243076295     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.009     Document Type: Conference Paper

References (108)

1. Adachi M., Reid G., Schuetz J.D. Therapeutic and biological importance of getting nucleotides out of cells: a case for ABC transporters, MRP4 and 5. Adv. Drug Deliv. Rev. 54:2002;1333-1342
2. Albuquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther. 280:1997;1117-1136
3. Ariano M.A., Lewicki J.A., Brandwein J.H., Murad F. Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc. Natl. Acad. Sci. U.S.A. 79:1982;1316-1320
4. Benveniste H. Brain microdialysis. J. Neurochem. 52:1989;1667-1679
5. Bhat G.K., Manesh V.B., Lamar C.A., Ping L., Aguan K., Brann D.W. Histochemical localization of nitric oxide neurons in the hypothalamus: association with gonadotropin-releasing hormone neurons and colocalization with N-methyl-D-aspartate receptors. Neuroendocrinology. 62:1995;187-197
6. Bito L., Davson H., Levin E., Murray M., Snider N. The concentrations of free amino acids and other electrolytes in cerebrospinal fluid, in vivo dialysate of brain, and blood plasma of the dog. J. Neurochem. 13:1966;1057-1067
7. Boegman R.J., Bates L.A. Neurotoxicity of aluminium. Can. J. Physiol. Pharmacol. 62:1984;101-1014
8. Bonavera J.J., Sahu A., Kalra P.S., Kalra P.S. Evidence that nitric oxide (NO) may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology. 133:1993;2481-2487
9. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87:1990;682-685
10. Breer H., Shepherd G.M. Implications of the NO/cGMP system for olfaction. Trends Neurosci. 16:1993;5-9
11. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., Valtschanoff J.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 22:2002;8961-8970
12. Burgunder J.M., Cheung P.T. Expression of soluble guanylyl cyclase gene in adult rat brain. Eur. J. Pharmacol. 6:1994;211-217
13. 3H -muscimol. In: Palay, S.L., Chan Palay, V. (Eds.), The Cerebellum - New Vistas. Springer Verlag, Berlin, pp. 552-586.
14. Chen Z.S., Lee K., Kruh G.D. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J. Biol. Chem. 276:2001;33747-33754
15. Consolo, S., Palazzi, E., Bertorelli, R., Fisone, G., Crawley, J., Hökfelt, T., Bartfai, T., 1990. Functional aspects of acetylcholine-galanin coexistence in the brain. In: Aquilonius, S.M., Gillberg, P.G. (Eds.), Progress in Brain Research. Elsevier Biomedical, Amsterdam, pp. 279-287.
16. Consolo S., Uboldi M.C., Caltavuturo C., Bartfai T. Galanin stimulates the N-methyl-D-aspartate receptor nitric oxide cyclic GMP pathway in vivo in the rat ventral hippocampus. Neuroscience. 85:1998;819-826
17. Cucarella C., Montoliu C., Hermenegildo C., Saez R., Manzo L., Minana M.D., Felipo V. Chronic exposure to aluminium impairs neuronal glutamate-nitric oxide-cyclic GMP pathway. J. Neurochem. 70:1998;1609-1614
18. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661
19. De Camilli P., Miller P.E., Levitt P., Walter U., Greengard P. Anatomy of cerebellar Purkinje cells in the rat determined by a specific immunohistochemical marker. Neuroscience. 11:1984;761-817
20. Decker M.W., Majchrzak M.J., Arneric S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45:1993;571-576
21. Dinerman J.L., Dawson T.M., Schell M.J., Snowman A., Snyder S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 91:1994;4214-4218
22. Donoso A., Lopez F.J., Negro-Vilar A. Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro. Endocrinology. 126:1990;414-420
23. Drummond G.S., Kappas A. Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. Proc. Natl. Acad. Sci. U.S.A. 78:1981;6466-6470
24. 1 pyramidal neurons from ventral hippocampus. Eur. J. Pharmacol. 164:1989;355-360
25. Fedele E., Raiteri M. Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cGMP microdialysis study in rat cerebellum. Br. J. Pharmacol. 117:1996;1133-1138
26. Fedele E., Raiteri M. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway. Prog. Neurobiol. 58:1999;89-120
27. Fedele E., Jin Y., Varnier G., Raiteri M. In vivo microdialysis study of specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cGMP pathway. Br. J. Pharmacol. 119:1996;590-594
28. Fedele E., Bisaglia M., Raiteri M. D-Serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis. Naunyn-Schmiedebergs' Arch. Pharmacol. 355:1997a;43-47
29. Fedele E., Conti A., Raiteri M. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences. Neuropharmacology. 36:1997b;1393-1403
30. B receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus. Neuropharmacology. 36:1997c;1405-1415
31. Fedele E., Varnier G., Ansaldo M.A., Raiteri M. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmacol. 125:1998;1042-1048
32. A receptors limit the activity of the NMDA/NO/cyclic GMP pathway: a microdialysis study in the cerebellum of freely moving rats. J. Neurochem. 75:2000;782-787
33. Garthwaite J., Brodbelt A.R. Glutamate as the principal mossy fibre transmitter in rat cerebellum: pharmacological evidence. Eur. J. Neurosci. 2:1989;177-180
34. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388
35. Globus M.Y., Prado R., Busto R. Ischemia-induced changes in extracellular levels of striatal cyclic GMP: role of nitric oxide. Neuroreport. 6:1995;1909-1912
36. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18:1998;2040-2055
37. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292
38. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature. 383:1996;713-716
39. Guo Y., Kotova E., Chen Z.S., Lee K., Hopper-Borge E., Belinsky M.G., Kruh G.D. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2′,3′- dideoxycytidine and 9′-(2′phosphonylmethoxyethyl)adenine. J. Biol. Chem. 278:2003;29509-29514
40. Hermenegildo C., Montoliu C., Llansola M., Munoz M.D., Gaztelu J.M., Minana M.D., Felipo V. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons and in the rat in vivo. Eur. J. Neurosci. 10:1998;3201-3209
41. Hermenegildo C., Saez R., Minoia C., Manzo L., Felipo V. Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo. Neurochem. Int. 34:1999;245-253
42. Hermenegildo C., Monfort P., Felipo V. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis. Hepatology. 31:2000;709-715
43. Hernandez-Viadel M., Montoliu C., Monfort P., Canales J.J., Erceg S., Rowan M., Ceccatelli S., Felipo V. Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo. Neurochem. Int. 42:2003;525-533
44. Hilgier W., Anderzhanova E., Oja S.S., Saransaari P., Albrecht J. Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. Eur. J. Pharmacol. 468:2003;21-25
45. Hirrlinger J., Konig J., Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J. Neurochem. 82:2002;716-719
46. Hirsch E.C., Brandel J.P., Galle P., Javoy-Agid F., Agid Y. Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J. Neurochem. 56:1991;446-451
47. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108
48. Hussain S., Gardner C.R., Bagust J., Walker R.J. Receptor subtypes involved in responses of Purkinje cell to exogenous excitatory amino acids and local electrical stimulation in cerebellar slices in the rat. Neuropharmacology. 30:1991;1029-1037
49. Ignarro L.J., Ballot B., Wood K.S. Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J. Biol. Chem. 259:1984;6201-6207
50. Jedlitschky G., Burchell B., Keppler D. The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J. Biol. Chem. 275:2000;30069-30074
51. Jhamandas J.H., Harris K.H., MacTavish D., Jassar B.S. Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. J. Neurophysiol. 87:2002;696-704
52. Kendrick K.M., Guevara-Guzman R., Zorrilla J., Hinton M.R., Broad K.D., Mimmack M., Ohkura S. Formation of olfactory memories mediated by nitric oxide. Nature. 388:1997;670-674
53. Krasavage W.J., O'Donoghue J.L., Di Vicenzo G.D., Terhaar C.J. The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. Toxicol. Appl. Pharmacol. 52:1980;433-441
54. Lai L., Tan T.M. Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem. J. 361:2002;497-503
55. Laitinen J.T., Laitinen K.S.M., Tuomisto L., Airaksinen M.M. Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: an in vivo microdialysis study. Brain Res. 668:1994;117-121
56. Laitinen J.T., Juvonen R.O. A sensitive microassay reveals marked regional differences in the capacity of rat brain to generate carbon monoxide. Brain Res. 694:1995;246-252
57. Laitinen K.S., Salovaara K., Severgnini S., Laitinen J.T. Regulation of cyclic GMP levels in the rat frontal cortex in vivo: effects of exogenous carbon monoxide and phosphodiesterase inhibition. Brain Res. 755:1997;272-278
58. Levin E.D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431
59. Lohmann S.M., Walter U., Miller P.E., Greengard P., De Camilli P. Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 78:1981;653-657
60. Lukiw, W.J., 1997. Alzheimer's disease and aluminium. In: Yasui, M., Strong, M.J., Ota, K., Verity, M.A. (Eds.), Mineral and Metal Neurotoxicology. CRC Press, New York, pp. 113-126.
61. Luo D., Vincent S.R. Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo. Eur. J. Pharmacol. 267:1994;263-267
62. Luo D., Leung E., Vincent S.R. Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex. J. Neurosci. 14:1994;263-271
63. Masu M., Tanabe Y., Tsuchida K., Shigemoto R., Nakanishi S. Sequence and expression of a metabotropic glutamate receptor. Nature. 349:1991;760-765
64. Matsuoka I., Giuili G., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360
65. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role R.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696
66. Meffert M.K., Haley J.E., Schuman E.M., Schulman H., Madison D.W. Inhibition of hippocampal heme-oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron. 13:1994;1225-1233
67. Miki N., Kawabe Y., Kuriyama K. Activation of cerebral guanylate cyclase by nitric oxide. Biochem. Biophys. Res. Commun. 75:1977;851-856
68. Monfort P., Corbalan R., Martinez L., Lopez-Talavera J.C., Cordoba J., Felipo V. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anostomosis. Neuroscience. 104:2001;1119-1125
69. Moretto M., Lopez F.J., Negro-Vilar A. Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology. 133:1993;2399-2402
70. Nakane M., Ichikawa M., Deguchi T. Light and electron microscopic demonstration of guanylate cyclase in rat brain. Brain Res. 273:1983;9-15
71. Nicoletti F., Wroblewski J.T., Novelli A., Alho H., Guidotti A., Costa E. The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells. J. Neurosci. 6:1986;1905-1911
72. Nomikos G.G., Gruber S., Svensson T.H., Mathé A.A. Effects of acute and chronic electroconvulsive stimuli on cAMP and cGMP efflux in the rat striatum and hippocampus. Eur. Neuropsychopharmacol. 10:2000;495-500
73. 2+ channels. J. Neurochem. 56:1991;739-747
74. Palmer R.M., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526
75. A, but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex, Neuropharmacology 46, 480-489.
76. Pin J.P., Joly C., Heinemann S.F., Bockaert J. Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 13:1994;342-348
77. Platt B., Carpenter D.O., Busselberg D., Reyman K.G., Riedel G. Aluminium impairs long-term potentiation in rats in vitro and in vivo. Exp. Neurol. 134:1995;73-86
78. Platt B., Haas H., Busselberg D. Aluminium reduces glutamate-activated currents of rat hippocampal neurones. Neuroreport. 5:1994;2329-2332
79. Provan S.D., Yokel R.A. Aluminium inhibits glutamate release from transverse rat hippocampal slices: role of G proteins, Ca channels and protein kinase C. Neurotoxicology. 13:1992;413-420
80. Pu S., Xu B., Kalra S.P., Kalra P.S. Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion. Endocrinology. 137:1996;1949-1955
81. Pu S., Kalra P.S., Kalra S.P. Diurnal rhythm in cyclic GMP/nitric oxide efflux in the medial preoptic area of male rats. Brain Res. 808:1998a;310-312
82. Pu S., Kalra P.S., Kalra S.P. Ovarian steroid-independent diurnal rhythm in cyclic GMP/nitric oxide efflux in the medial preoptic area: possible role in preovulatory and ovarian steroid-induced LH surge. J. Neuroendocrinol. 10:1998b;617-625
83. Schlichter D.J., Detre J.A., Aswad D.W., Cherazi B., Greengard P. Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum. Proc. Natl. Acad. Sci. U.S.A. 77:1980;5537-5541
84. Seeburg P.H. The TINS/TiPS Lecture. The molecular biology of mammalian glutamate receptor channels. Trends Neurosci. 16:1993;359-365
85. Sekine T., Cha S.H., Endou H. The multispecific organic anion transporter (OAT) family. Pflugers Arch. 440:2000;337-350
86. Southam E., Garthwaite J. The nitric oxide-cyclic GMP signalling pathway in the rat brain. Neuropharmacology. 32:1993;1267-1277
87. Southam E., Morris R., Garthwaite J. Sources and targets of nitric oxide in rat cerebellum. Neurosci. Lett. 137:1992;241-244
88. Spencer P.S., Schaumburg H.H., Sabri M.I., Veronesi B.V. The enlarging view of hexacarbon neurotoxicity. Crit. Rev. Toxicol. 7:1980;279-356
89. + channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation. J. Neurosci. 16:1996;5004-5013
90. Timmerman W., Westerink B.H. Brain microdialysis of GABA and glutamate: what does it signify? Synapse. 27:1997;242-261
91. + or N-methyl-N′-nitro-N-nitrosoguanidine. Neurosci. Lett. 68:1986;95-99
92. Ungerstedt U., Pycock C. Functional correlates of dopamine transmission. Bull. Schweiz. Akad. Med. Wiss. 1278:1974;1-13
93. Ungerstedt U., Herrera-Marschitz M., Zetterstrom T. Dopamine neurotransmission and brain function. Prog. Brain Res. 55:1982;41-49
94. Urushitani M., Shimohama S., Kihara T., Sawada H., Akaike A., Ibi M., Inoue R., Kitamura Y., Taniguchi T., Kimura J. Mechanisms of selective motor neuronal death after exposure of spinal cord to glutamate: involvement of glutamate-induced nitric oxide in motor neuron toxicity and nonmotor neuron protection. Ann. Neurol. 44:1998;796-807
95. Vallebuona F., Raiteri M. Monitoring of cGMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity. Neuroscience. 57:1993;577-585
96. Vallebuona F., Raiteri M. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity. J. Neurosci. 14:1994;134-139
97. Valtschanoff J.G., Weinberg R.J., Kharazia V.N., Nakane H., Schmidt H.H.H.W. Neurons in rat hippocampus that synthesize nitric oxide. J. Comp. Neurol. 331:1993;111-121
98. Varnier G., Fedele E., Marchi M., Raiteri M. Intracerebral administration of L-kynurenine decreases N-methyl-D-aspartate receptor-mediated production of cGMP in the cerebellum and hippocampus of unanaesthetized rats subjected to transcerebral microdialysis. Neurosci. Lett. 266:1999;81-84
99. Vincent S.R., Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience. 46:1992;755-784
100. Warburton D.M. Nicotine as a cognitive enhancer. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;181-191
101. Wendland B., Schweizer F.E., Ryan T.A., Nakane M., Murad F., Scheller R.H., Tsien R.W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2151-2155
102. Whitehouse P.J., Kalaria R.N. Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis. Assoc. Disord. 9:1995;3-5
103. Wilson A.L., Langley L.K., Monley J., Bauer T., Rottunda S., McFalls E., Kovera C., McCarten J.R. Nicotine patches in Alzheimer's disease: pilot study on learning, memory and safety. Pharmacol. Biochem. Behav. 51:1995;509-514
104. Wong P.C., Lai J.C., Lim L., Davidson A.N. Selective inhibition of L-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese and cadmium chloride. J. Inorg. Biochem. 14:1981;253-260
105. Wynick D., Smith D.M., Ghatei M., Akinsanya K., Bhogal R., Purkiss P., Byfield P., Yanaihara N., Bloom S.R. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;4231-4235
106. Zarrindast M.R., Sadegh M., Shafaghi B. Effects of nicotine on memory retrieval in mice. Eur. J. Pharmacol. 295:1996;1-6
107. Zini S., Roisin M.P., Langel U., Bartfai T., Ben-Ari J. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur. J. Pharmacol. 245:1993;1-7
108. Zwiller J., Ghandour M.S., Revel M.O., Basset P. Immunohistochemical localization of guanylate cyclase in rat cerebellum. Neurosci. Lett. 23:1981;31-36